Hilbi
Hilbi is building what it says is the first decentralized healthcare Artificial intelligence (AI) that will allow all users to share, use and monetize any kind of health data in an anonymous way. Designed as a communication platform meeting the real needs of patients and physicians in treatment processes and prevention, it can protect the user's health by safely storing and enriching their health data which then enables the system to detect early disease symptoms. Hilbi's platform consists of a few parts, including Medical Chat (a secure chat and chatbot platform made for the needs of the medical industry), Life ID (that doubles as an EHR system in which the data is secured by blockchain technology), and Medical Manager (that supports services such as e-Prescription, e-Visit, e-Wallet, e-Invoices, and more).
Select partners: TMF Group, CareSee, 01People, CompuGroup Medical.
Sections Healthcare Platform
Technologies Blockchain
Funding 💰
Total €5M
Select investors Daren Wilson
Key people 🧑🤝🧑
- Patrik Kmeč - CEO
- Roman Kučera - CTO
- Jozef Repáň - Chief Information Security Officer
- MUDr. Mgr. Andrea Švrčková, MHA - Inovator of Healthcare
- Lukáš Rosenberg - Head of Product & Business Development
- Júlia Speváková - Project Manager
Highlights ⭐
- Patient-centric approach: This, the company claims, allows it to securely and systematically connect physicians and patients anywhere in the world. On the other hand, Hilbi provides physicians with an easy-to-use telehealth service that saves them time and brings new possibilities in personalized healthcare.
- Roadmap for growth: The company's plans include expansion to the rest of Europe, the MENA region, the United States and Asia.
- Media love: The company has been featured in a few media outlets, including Bloomberg, USA Today, MarketWatch and Yahoo! Finance.
Video ▶️
Quotes 💬
“
There are thousands of digital health apps across multiple diseases. Now, imagine if there was just one app to support the entire ecosystem around the patient. Hilbi has this potential. Their business model is different as they add more value and trust towards physician-patient relationships so that the patient can benefit from the highest quality of care from their health professionals.
— Daren Wilsonm Hibi's investors 🔗
“
It is fantastic what the team working on Hilbi wants to achieve. It is not enough to make a diagnosis based only on a list of symptoms. Important factors are genetic and geographical factors connected to patients ́ lifestyle. This technology records all of these factors and helps to diagnose patients faster and more accurately.
— Emmanuel Fombu, MD, MBA, Global Strategy and Digital Innovation Leader at Johnson & Johnson
“
I believe that this is the right concept, because the one who is most aware of the benefits applies = the patient. A huge advantage is also that the patient's costs are in the order of units of euros per month. For this price, the patient gets an innovative tool for communication with his doctor, whom he knows well, and therefore a high level of mutual trust is set from the beginning. With his new approach, Hilbi can speed up the digitalization of healthcare and that is why I am very much a fan of him.
— Vladimir Prikryl, Executive Director at LutherOne
“
Personally, I'm impressed by what Hilbi's developing and I clearly see the great value the product will create for patients and all other stakeholders in the healthcare sector. There's an extraordinary personal story behind the idea and a unique team drive. I can see an opportunity to develop an HR administrative service to clients that offer Hilbi as benefit to their employees, initially in Slovakia to test the case with a potential to expand as Hilbi grows across borders. Some work to be done before this can go live but a real potential.
— Juraj Gerzeni, Head of EMEA at TMF Group
Last update: August 15, 2022
Disclaimer: We can not guarantee that the information on this page is 100% correct. more